Recently published long-term data confirms what has been known for some time: that the addition of the platinum chemotherapy drug cisplatin to radiotherapy can reduce the risk of death in patients with cervical cancer by as much as 23%.
The combination treatment regimen has long been used as a potential cure for cervical cancer, but this most recent research is the first to indicate just how effective this combination is in reducing the risk of death among this patient population.
The 23% risk in death was derived from retrospectively comparing the outcomes of women with cervical cancer who received both cisplatin and radiotherapy against women treated with radiotherapy alone.
CANCER TYPE(S)
Cervical cancer
TREATMENT TYPE(S)
Chemotherapy and radiotherapy
WHERE WAS THIS RESEARCH PUBLISHED?
Clinical Oncology
By Ross Bonander
Source
Google News
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.
